<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1376721</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2024.1376721</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Construction of a ceRNA network and screening of potential biomarkers and molecular targets in male smokers with chronic obstructive pulmonary disease</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2024.1376721">10.3389/fgene.2024.1376721</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Jihua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2757250/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Xu</surname>
<given-names>Shuanglan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2756453/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1866938/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2756397/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Zeqin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2756951/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Yunchun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2575435/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Basnet</surname>
<given-names>Jorina</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2756472/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Liqiong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1145692/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2756604/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Jiao</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2756910/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xing</surname>
<given-names>Xiqian</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2640202/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Respiratory Medicine</institution>, <institution>The People&#x2019;s Hospital of Yuxi City</institution>, <institution>The Sixth Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Yuxi</addr-line>, <addr-line>Yunnan</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Respiratory Disease Research of Department of Education of Yunnan Province, Department of Respiratory Medicine</institution>, <institution>The Affiliated Hospital of Yunnan University</institution>, <institution>The Second People&#x2019;s Hospital of Yunnan Province</institution>, <addr-line>Kunming</addr-line>, <addr-line>Yunnan</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Dermatology and Venereology</institution>, <institution>The Second Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Kunming</addr-line>, <addr-line>Yunnan</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Graduate School</institution>, <institution>Kunming Medical University</institution>, <addr-line>Kunming</addr-line>, <addr-line>Yunnan</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>First Department of Respiratory Medicine</institution>, <institution>The First Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Kunming</addr-line>, <addr-line>Yunnan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/705222/overview">Qiu-Ning Liu</ext-link>, Yancheng Teachers University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1302613/overview">Milad Shirvaliloo</ext-link>, Iran University of Medical Sciences, Iran</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1537892/overview">Dharmendra Kumar Soni</ext-link>, Uniformed Services University of the Health Sciences, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jiao Yang, <email>yangjiao@kmmu.edu.cn</email>; Xiqian Xing, <email>xingxiqiankm@163.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1376721</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Zhang, Xu, Liu, Liu, Fan, Zhou, Basnet, Zhang, Li, Yang and Xing.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhang, Xu, Liu, Liu, Fan, Zhou, Basnet, Zhang, Li, Yang and Xing</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Circular RNAs (circRNAs) play an important role in the occurrence and development of diseases. However, the role of circRNAs in male smokers with chronic obstructive pulmonary disease (COPD) remains unclear.</p>
</sec>
<sec>
<title>Methods</title>
<p>Stable COPD patients and healthy controls were recruited. Peripheral blood mononuclear cells (PBMCs) were extracted. After high-throughput RNA sequencing (RNA-Seq) of PBMCs, a bioinformatics method was used to analyse differentially expressed (DE) circRNAs (DEcircRNAs) and mRNAs (DEmRNAs).</p>
</sec>
<sec>
<title>Results</title>
<p>Total of 114 DEcircRNAs and 58 DEmRNAs were identified. Functional enrichment analysis showed that processes related to COPD include the regulation of interleukin (IL)-18, IL-5 and the NLRP3 inflammasome; differentiation of T helper type 1 (Th1), Th2, and Th17 cells, and the AMPK, Wnt, JAK-STAT, and PI3K-Akt signalling pathways. In the protein&#x2013;protein interaction (PPI) network, the core genes were MYO16, MYL4, SCN4A, NRCAM, HMCN1, MYOM2, and IQSEC3. Small-molecule prediction results revealed potential drugs for the COPD treatment. Additionally, the circRNA-miRNA-mRNA competitive endogenous RNA (ceRNA) regulatory network was constructed.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study identified a set of dysregulated circRNAs and mRNAs and revealed potentially important genes, pathways, new small-molecule drugs and ceRNA regulatory networks in male smokers with COPD. These circRNAs might be prospective biomarkers or potential molecular targets of the ceRNA mechanism for COPD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>chronic obstructive pulmonary disease</kwd>
<kwd>circular RNAs</kwd>
<kwd>competitive endogenous RNA</kwd>
<kwd>biomarker</kwd>
<kwd>target</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>RNA</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Chronic obstructive pulmonary disease (COPD), a progressive and irreversible lung disease, was the third leading cause of death globally until 2019, when it fell to the fourth leading cause of death globally due to the impact of the COVID-19 pandemic. Despite this drop in ranking, high rates of morbidity, disability, and mortality of COPD remain a global public health issue causing a very large social and economic burden worldwide (<xref ref-type="bibr" rid="B12">Global burden, 2024</xref>). The Global Burden of Disease Study reported a death of 3.2 million COPD patients globally in 2017 (<xref ref-type="bibr" rid="B11">Gbd, 2018</xref>). Much research has confirmed cigarette smoking as one of the major risk factors for COPD, and passive smoking exposure was independently associated with COPD (<xref ref-type="bibr" rid="B14">Hagstad et al., 2014</xref>; <xref ref-type="bibr" rid="B37">Wang et al., 2018a</xref>); however, the mechanism of smokers with COPD is unclear. For example, although lung fibroblasts have been identified as an important component of the remodelling process in COPD, the effect of smoking on lung fibroblasts in COPD subjects remains poorly understood (<xref ref-type="bibr" rid="B10">Garcia-Ryde et al., 2023</xref>). Whilst multiciliated cell loss or dysfunction is common in smokers and patients with COPD, it is not clear whether this contributes to the development of COPD lesions in the lungs of smokers (<xref ref-type="bibr" rid="B26">Richmond et al., 2024</xref>). In addition, the role of newly identified endogenous non-coding RNAs, which are genetically regulated in COPD, is not well understood (<xref ref-type="bibr" rid="B31">Shen et al., 2024</xref>). Therefore, there is of great significance to discover novel biomarkers or molecular mechanisms to promote the early screening, detection and management of smokers with COPD.</p>
<p>Circular RNAs (circRNAs) are newly identified non-coding RNA molecules that were originally considered to be &#x201c;noise&#x201d; from transcription that lacked any important biological effects (<xref ref-type="bibr" rid="B3">Cocquerelle et al., 1993</xref>). Subsequently, increasing evidence shows that abnormally expressed circRNAs are involved in many important pathophysiological processes and could be used as diagnostic biomarkers and therapeutic targets (<xref ref-type="bibr" rid="B21">Memczak et al., 2013</xref>; <xref ref-type="bibr" rid="B32">Sheng et al., 2018</xref>; <xref ref-type="bibr" rid="B25">Qiu et al., 2019</xref>; <xref ref-type="bibr" rid="B29">Santer et al., 2019</xref>; <xref ref-type="bibr" rid="B33">Sheng et al., 2020</xref>). It is worth mentioning that circRNAs act as a natural sponge to adsorb miRNAs and regulate the expression of downstream genes, which is as the definition of the mechanism of the competitive endogenous RNA (ceRNA) hypothesis (<xref ref-type="bibr" rid="B27">Salmena et al., 2011</xref>). This circRNA-related mechanism has received increasing attention in the pathogenesis of various human tumours, such as hepatocellular cancer, breast cancer and prostate cancer (<xref ref-type="bibr" rid="B17">Huang et al., 2019</xref>; <xref ref-type="bibr" rid="B28">Sang et al., 2019</xref>; <xref ref-type="bibr" rid="B39">Wang et al., 2019</xref>). To date, the significant function and ceRNA mechanism of circRNAs in the pathogenesis of COPD remains inconclusive.</p>
<p>In the current study, we investigated deregulated circRNAs and mRNAs from peripheral blood mononuclear cells (PBMCs) in male smokers with COPD by using high-throughput RNA sequencing (RNA-Seq) and bioinformatics analysis. This study aimed to explore possible underlying new biomarkers or molecular regulation mechanisms of circRNAs in COPD.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Participant screening</title>
<p>Ten male clinical participants who smoked, including five stable COPD patients and five healthy controls, were selected on November 2019. It should be noted that the 10 smokers were in a state of abstinence when they participated in the experiment. The inclusion criteria were as follows: (1) COPD diagnosed using the ratio of postbronchodilator the forced expiratory volume in the first one second to the forced vital capacity of the lungs (FEV1/FVC). Combined with clinical manifestations, if postbronchodilator FEV1/FVC &#x3c;70%, the patients were diagnosed with COPD. (2) The age of male smokers was between 50 and 80 years old, and the number of years of smoking was between 30 and 50 years. (3) The participants were from Yunnan Province to exclude the impact of different altitudes from different provinces on COPD. (4) There were no other respiratory diseases, including asthma, bronchiectasis, pulmonary fibrosis, lung tumor and tuberculosis. Healthy control individuals had no clinical symptoms of any respiratory disease, such as cough, sputum, and wheezing.</p>
<p>All the data were expressed as the mean &#xb1; standard deviation (SD). This study was approved by the Ethics Committee of The Affiliated Hospital of Yunnan University (No. 2020139), and each participant signed the informed consent form before the collection of blood samples.</p>
</sec>
<sec id="s2-2">
<title>2.2 Blood sample collection and PBMC extraction</title>
<p>Peripheral blood samples (20&#xa0;mL) were collected from the median cubital vein from all participants. Then, they were placed into 5&#xa0;mL purple-head EDTA-K2 anticoagulation tubes and mixed gently by inversion for subsequent experiments. Based on the manufacturer&#x2019;s instructions for Human Lymphocyte Separation Medium (DAKEWEI, Beijing, China), PBMCs were isolated and extracted within 4&#xa0;h.</p>
</sec>
<sec id="s2-3">
<title>2.3 High-throughput RNA-Seq</title>
<p>Total RNA was extracted from PBMCs using TRIzol reagent (Invitrogen, USA) according to the manufacturer&#x2019;s instructions. After successful RNA quality and integrity testing, the ribosomal RNA removal kit was used to remove ribosomal RNA (rRNA) from the total RNA, and then the RNA was broken into fragments of approximately 300&#xa0;bp in length by ion interruption. cDNA libraries were generated by polymerase chain reaction (PCR) amplification for the enrich library fragments. Then, the Agilent 2,100 Bioanalyzer was used for quality inspection of the library, including the total concentration and effective concentration. After the quality inspection results were passed, next-generation sequencing (NGS) technology was used to perform paired-end sequencing of these libraries based on the Illumina HiSeq sequencing platform (Personalbio, Shanghai, China).</p>
<p>After data filtering (Cutadapt) and quality evaluation (FastQC), the RNA-Seq data were compared to the reference genome (TopHat2), and the data source for the reference genome was the Ensembl database (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/">http://www.ensembl.org/</ext-link>, Homo_sapiens.GRCh38.dna.primary assembly.fa). Then, we used HTSeq to compare the read count value of each gene as the original expression of the gene and Fragments Per Kilobase of transcript per Million mapped reads (FPKM) to normalize the expression. These RNA-Seq data include circRNAs and mRNAs.</p>
</sec>
<sec id="s2-4">
<title>2.4 Differential expression analysis</title>
<p>After filtering the original offline data, the sequences from these data were compared to that of the reference genome of humans, and the expression of each gene was calculated. R software (version number: 3.4.1, <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>) was used to normalize and standardize the data, and the DESeq R package was used for differentially expressed gene (DEG) analysis (<xref ref-type="bibr" rid="B34">Sun et al., 2013</xref>). Under the conditions of a &#x7c;log2FoldChange&#x7c; value &#x3e; 1 and a significant <italic>p</italic>-value &#x3c; 0.05, differentially expressed (DE) circRNAs (DEcircRNAs) and mRNAs (DEmRNAs) were identified. To show the characteristics of DEGs, volcano maps and hierarchical bidirectional clustering analysis were generated using the ggplots2 R package. In addition, we used the circlize R package to label DEGs in the genome in a genomic circle diagram based on the genomic information and the RNA differential expression analysis results.</p>
</sec>
<sec id="s2-5">
<title>2.5 Functional and pathway enrichment analyses</title>
<p>Gene Ontology (GO, <ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</ext-link>) functional enrichment analysis of DEGs covers three domains, i.e., biological processes (BPs), cellular components (CCs), and molecular functions (MFs). The Kyoto Encyclopedia of Genes and Genomes (KEGG, <ext-link ext-link-type="uri" xlink:href="http://www.kegg.jp/">http://www.kegg.jp/</ext-link>) contains a gene information database, a system information database, and a chemical information database. The topGO and <ext-link ext-link-type="uri" xlink:href="https://github.com/Cassiel60/R/blob/master/pathview.pdf">pathview</ext-link> R packages were used for GO enrichment analysis, and a <italic>p</italic>-value &#x3c;0.05 was defined as statistically significant.</p>
</sec>
<sec id="s2-6">
<title>2.6 PPI network</title>
<p>The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>) was used to construct the protein&#x2013;protein interaction (PPI) networks of integrated DEGs (<xref ref-type="bibr" rid="B35">Szklarczyk et al., 2019</xref>). The minimum required interaction score was 0.15. The obtained results were imported into Cytoscape version 3.6.1. The cytoHubba plugin provides a user-friendly interface to explore important nodes in PPI networks by the multiscale curvature classification (MCC) algorithm (score &#x2265;5), and it was used to select the hub node, which is named the core gene or core protein (<xref ref-type="bibr" rid="B2">Chin et al., 2014</xref>).</p>
</sec>
<sec id="s2-7">
<title>2.7 Identification of small-molecule candidate drugs</title>
<p>The Connectivity Map (CMap), a database of biological applications, revealed the relationship of small-molecule drugs, gene expression levels and interrelated diseases (<xref ref-type="bibr" rid="B9">Gao et al., 2019</xref>). In other words, the gene expression profile was used to establish the association between genes, diseases and drugs, which should help scholars to quickly identify highly associated genes with a disease, identify the main chemical structure of a molecule, and summarize the possible directions of the mechanism of drug molecules.</p>
</sec>
<sec id="s2-8">
<title>2.8 Construction of the ceRNA regulatory network</title>
<p>The regulatory relationships of the DEcircRNA-DEmiRNA pairs and DEmiRNA-DEmRNA pairs were predicted based on the CircInteractome (<ext-link ext-link-type="uri" xlink:href="https://circinteractome.nia.nih.gov/">https://circinteractome.nia.nih.gov/</ext-link>), StarBase (<ext-link ext-link-type="uri" xlink:href="http://starbase.sysu.edu.cn/">http://starbase.sysu.edu.cn/</ext-link>), TargetScan (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org/">http://www.targetscan.org/</ext-link>), miRTarBase (<ext-link ext-link-type="uri" xlink:href="http://mirtarbase.mbc.nctu.edu.tw/">http://mirtarbase.mbc.nctu.edu.tw/</ext-link>), miRDB (<ext-link ext-link-type="uri" xlink:href="http://www.mirdb.org/">http://www.mirdb.org/</ext-link>), miRanda (<ext-link ext-link-type="uri" xlink:href="http://www.microrna.org/">http://www.microrna.org/</ext-link>) and miRBase (<ext-link ext-link-type="uri" xlink:href="http://www.mirbase.org/">http://www.mirbase.org/</ext-link>) databases (<xref ref-type="bibr" rid="B8">Fan et al., 2016</xref>; <xref ref-type="bibr" rid="B7">Fan et al., 2018</xref>). Then, the intersection of predicted target genes and DEmRNAs was analysed by the custom Venn diagram tool. The circRNA acts as a competitive endogenous RNA (ceRNA) to competitively bind with miRNA and to regulate the expression of downstream genes and proteins. According to the ceRNA theory, a circRNA-miRNA-mRNA ceRNA regulatory network was constructed by Cytoscape version 3.6.1 (<xref ref-type="bibr" rid="B30">Shannon et al., 2003</xref>), integrating circRNA-miRNA pairs and miRNA-mRNA pairs.</p>
</sec>
<sec id="s2-9">
<title>2.9 Real-time quantitative PCR (RT-qPCR)</title>
<p>Total RNA was extract from PBMCs by TRIzol (Invitrogen, USA). cDNA was synthesized using a reverse transcription kit (Vazyme Biotech Co., Ltd., Nanjing, China). qPCR was conducted using the SYBR Master Mix Kit (Vazyme, Nanjing, China) in an ABI 7500 PCR System (Applied Biosystems, CA, USA). The PCR conditions were 95&#xb0;C for 5&#xa0;min, followed by 40 cycles of 95&#xb0;C for 15&#xa0;s and 60&#xb0;C for 30&#xa0;s. Data were normalized using small&#x2002;nuclear&#x2002;RNA 6 (U6) for circRNAs, GAPDH for mRNAs as a reference gene. The relative expression was calculated using the 2<sup>&#x2212;&#x394;&#x394;CT</sup> method. The primer for RT-qPCR in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Primer for Quantitative real-time PCR (qRT-PCR).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Gene names</th>
<th align="center">Forward-primer sequence (5&#x2032;-3&#x2032;)</th>
<th align="center">Reverse-primer sequence (5&#x2032;-3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">hsa_circ_006155</td>
<td align="left">GCC&#x200b;AGG&#x200b;ACT&#x200b;CCC&#x200b;AAT&#x200b;CTT&#x200b;GTA&#x200b;A</td>
<td align="left">AGT&#x200b;TAC&#x200b;TGG&#x200b;TGG&#x200b;AGT&#x200b;TGA&#x200b;ACC&#x200b;TT</td>
</tr>
<tr>
<td align="left">hsa_circ_007446</td>
<td align="left">TTC&#x200b;TCA&#x200b;AGT&#x200b;GGT&#x200b;TCA&#x200b;GGT&#x200b;GGT&#x200b;T</td>
<td align="left">CAC&#x200b;TGC&#x200b;TTC&#x200b;CTC&#x200b;CAC&#x200b;ATT&#x200b;CCT&#x200b;C</td>
</tr>
<tr>
<td align="left">hsa_circ_019015</td>
<td align="left">CTG&#x200b;ACC&#x200b;ATG&#x200b;TAA&#x200b;AGC&#x200b;AAT&#x200b;GCC&#x200b;A</td>
<td align="left">GGC&#x200b;CTT&#x200b;CTC&#x200b;ATC&#x200b;TTG&#x200b;CTT&#x200b;TGA&#x200b;G</td>
</tr>
<tr>
<td align="left">hsa_circ_031080</td>
<td align="left">TTC&#x200b;CTG&#x200b;ACA&#x200b;ATG&#x200b;GCA&#x200b;GAA&#x200b;TGT&#x200b;CAA&#x200b;T</td>
<td align="left">ACC&#x200b;ACC&#x200b;AAA&#x200b;GGT&#x200b;GTG&#x200b;AAA&#x200b;GAA&#x200b;C</td>
</tr>
<tr>
<td align="left">hsa_circ_038146</td>
<td align="left">CAA&#x200b;ATT&#x200b;CTG&#x200b;GAG&#x200b;CCT&#x200b;GCA&#x200b;TTG&#x200b;A</td>
<td align="left">AAT&#x200b;TCA&#x200b;ACA&#x200b;TCT&#x200b;CAG&#x200b;CTG&#x200b;TGC&#x200b;C</td>
</tr>
<tr>
<td align="left">hsa_circ_041434</td>
<td align="left">CAA&#x200b;CCT&#x200b;TGG&#x200b;AAA&#x200b;CAT&#x200b;TGC&#x200b;TCA&#x200b;GA</td>
<td align="left">GCT&#x200b;GCA&#x200b;TGG&#x200b;TCT&#x200b;GCT&#x200b;AAC&#x200b;ATT</td>
</tr>
<tr>
<td align="left">U6</td>
<td align="left">CTCGCTTCGGCAGCACA</td>
<td align="left">AAC&#x200b;GCT&#x200b;TCA&#x200b;CGA&#x200b;ATT&#x200b;TGC&#x200b;GT</td>
</tr>
<tr>
<td align="left">HYDIN</td>
<td align="left">TTA&#x200b;GAG&#x200b;GCT&#x200b;GTG&#x200b;TCA&#x200b;TTG&#x200b;GAC&#x200b;C</td>
<td align="left">AGT&#x200b;CCA&#x200b;CAT&#x200b;GCT&#x200b;GCT&#x200b;CAC&#x200b;AAT&#x200b;A</td>
</tr>
<tr>
<td align="left">MUC19</td>
<td align="left">CAA&#x200b;CAC&#x200b;CAT&#x200b;CTC&#x200b;ACC&#x200b;TAG&#x200b;CAG&#x200b;T</td>
<td align="left">TTA&#x200b;CTT&#x200b;CCA&#x200b;GCC&#x200b;TCA&#x200b;GTG&#x200b;GTT&#x200b;C</td>
</tr>
<tr>
<td align="left">MYZAP</td>
<td align="left">TTA&#x200b;ACA&#x200b;GAA&#x200b;ACC&#x200b;CAG&#x200b;GCC&#x200b;AAG&#x200b;A</td>
<td align="left">GGC&#x200b;ATC&#x200b;ACA&#x200b;ATT&#x200b;TCA&#x200b;CGA&#x200b;GTC&#x200b;C</td>
</tr>
<tr>
<td align="left">NRCAM</td>
<td align="left">TAG&#x200b;ACT&#x200b;GTG&#x200b;CCT&#x200b;TCT&#x200b;TTG&#x200b;GGT&#x200b;C</td>
<td align="left">AAC&#x200b;TTC&#x200b;ATT&#x200b;CTT&#x200b;CGC&#x200b;CAT&#x200b;CCC&#x200b;T</td>
</tr>
<tr>
<td align="left">RNF17</td>
<td align="left">TGG&#x200b;AAG&#x200b;GAG&#x200b;GGT&#x200b;ATC&#x200b;CAG&#x200b;ATC&#x200b;A</td>
<td align="left">AGC&#x200b;TGT&#x200b;AGC&#x200b;AAC&#x200b;CTC&#x200b;ACA&#x200b;ATC&#x200b;A</td>
</tr>
<tr>
<td align="left">SHE</td>
<td align="left">AGC&#x200b;TAT&#x200b;ACG&#x200b;ACA&#x200b;CTC&#x200b;CCT&#x200b;ACG&#x200b;A</td>
<td align="left">CTC&#x200b;AGC&#x200b;TCC&#x200b;TTC&#x200b;AAA&#x200b;CTG&#x200b;GAC&#x200b;T</td>
</tr>
<tr>
<td align="left">GAPDH</td>
<td align="left">GCAAGTTCAACGGCACAG</td>
<td align="left">GCC&#x200b;AGT&#x200b;AGA&#x200b;CTC&#x200b;CAC&#x200b;GAC&#x200b;AT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-10">
<title>2.10 Statistical analysis</title>
<p>The statistical analyses were performed using R software and SPSS. Among them, R software was used for the visualisation of the results of GO enrichment, KEGG function and differential gene analysis, and t-tests for RT-qPCR were performed with SPSS version 24.0 (SPSS, IL, USA). Additionally, independent samples t-tests were carried out using SPSS for age and years of smoking, and <italic>p</italic> &#x3e; 0.05 was deemed to be not statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Participant characteristics</title>
<p>The characteristics of the ten eligible participants are presented in <xref ref-type="table" rid="T2">Table 2</xref>, including five COPD patients and five healthy controls. All participants were male smokers with good general physical fitness from Yunnan Province. In the COPD group, the age range was 53&#x2013;76 years, the pack-years of smoking ranged from 40 to 52 years, and the FEV1/FVC values were all &#x3c;70%. In the control group, the age range was 58&#x2013;76 years, the pack-years of smoking ranged from 30 to 48 years, and the FEV1/FVC values were all &#x3e;70%. There were no statistically significant differences in age (66.00 &#xb1; 8.60 years vs. 65.40 &#xb1; 6.73 years, <italic>p</italic> &#x3e; 0.05) or number of years of smoking (44.00 &#xb1; 4.95 years vs. 38.00 &#xb1; 8.03 years, <italic>p</italic> &#x3e; 0.05) between the two groups.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Characteristics of the ten eligible participants.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Rank</th>
<th align="center">Gender</th>
<th align="center">Age (y)</th>
<th align="center">Years of smoking (y)</th>
<th align="center">Previous disease history</th>
<th align="center">FEV1/FVC (%)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">COPD 1</td>
<td align="center">Males</td>
<td align="center">63</td>
<td align="center">43</td>
<td align="left">hypertension, hyperlipidemia</td>
<td align="center">69.90</td>
</tr>
<tr>
<td align="center">COPD 2</td>
<td align="center">Males</td>
<td align="center">76</td>
<td align="center">52</td>
<td align="left">none</td>
<td align="center">65.61</td>
</tr>
<tr>
<td align="center">COPD 3</td>
<td align="center">Males</td>
<td align="center">69</td>
<td align="center">40</td>
<td align="left">none</td>
<td align="center">59.89</td>
</tr>
<tr>
<td align="center">COPD 4</td>
<td align="center">Males</td>
<td align="center">69</td>
<td align="center">45</td>
<td align="left">hyperlipidemia</td>
<td align="center">58.49</td>
</tr>
<tr>
<td align="center">COPD 5</td>
<td align="center">Males</td>
<td align="center">53</td>
<td align="center">40</td>
<td align="left">appendectomy</td>
<td align="center">28.99</td>
</tr>
<tr>
<td align="center">Control 1</td>
<td align="center">Males</td>
<td align="center">76</td>
<td align="center">48</td>
<td align="left">none</td>
<td align="center">85.89</td>
</tr>
<tr>
<td align="center">Control 2</td>
<td align="center">Males</td>
<td align="center">63</td>
<td align="center">45</td>
<td align="left">none</td>
<td align="center">73.93</td>
</tr>
<tr>
<td align="center">Control 3</td>
<td align="center">Males</td>
<td align="center">63</td>
<td align="center">35</td>
<td align="left">benign prostatic hyperplasia</td>
<td align="center">74.52</td>
</tr>
<tr>
<td align="center">Control 4</td>
<td align="center">Males</td>
<td align="center">67</td>
<td align="center">30</td>
<td align="left">none</td>
<td align="center">82.65</td>
</tr>
<tr>
<td align="center">Control 5</td>
<td align="center">Males</td>
<td align="center">58</td>
<td align="center">32</td>
<td align="left">none</td>
<td align="center">79.44</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: y, years; FEV1/FVC, ratio of forced expiratory volume to forced vital capacity in the first second.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Examination of the sample quality</title>
<p>Correlation analysis suggested that the correlation coefficient was highly strong (between 0.8-1), indicating that the similarity of the expression patterns between samples was high (<xref ref-type="fig" rid="F1">Figures 1A, D</xref>). Principal component analysis (PCA) determined patterns between similar samples, and if the distance is closer, the similarity between the samples is higher. Our results showed good similarity between samples in <xref ref-type="fig" rid="F1">Figures 1B, E</xref>. In addition, the distributions of the datasets for the circRNAs/mRNAs of the ten samples were nearly identical after normalization, as shown in violin plots (<xref ref-type="fig" rid="F1">Figures 1C, F</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Examination of samples quality for circRNAs and mRNAs. <bold>(A)</bold> The Correlation analysis of circRNAs samples. <bold>(B)</bold> The Principal Components Analysis of circRNAs samples. <bold>(C)</bold> The violin plots show the distribution of circRNAs. <bold>(D)</bold> The Correlation analysis of mRNAs samples. <bold>(E)</bold> The Principal Components Analysis of mRNAs samples. <bold>(F)</bold> The violin plots show the distribution of mRNAs. Con, Control Group; COPD, Chronic obstructive pulmonary disease.</p>
</caption>
<graphic xlink:href="fgene-15-1376721-g001.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Computational analysis of DEcircRNAs and DEmRNAs</title>
<p>By comparing the COPD group with the healthy control group using the screening criteria, there were 114 significant DEcircRNAs, in which 57 were upregulated (including the top 10 genes: hsa_circ_032857, hsa_circ_019208, hsa_circ_024906, hsa_circ_035125, hsa_circ_010451, hsa_circ_019753, hsa_circ_031856, hsa_circ_040189, hsa_circ_021622, and hsa_circ_003470), and 57 were downregulated (including the top 10 genes: hsa_circ_007446, hsa_circ_016302, hsa_circ_019528, hsa_circ_019015, hsa_circ_038146, hsa_circ_026711, hsa_circ_026970, hsa_circ_001331, hsa_circ_012036, and hsa_circ_012997), and 58 significant DEmRNAs, in which 21 were upregulated (including the top 10 genes: KCNJ12, SHE, GCOM1, NRCAM, MYZAP, TMEM178B, SEMA5A, VSTM4, MYOM2, and MYL4), and 37 were downregulated (including the top 10 genes: GDF15, RNF17, HYDIN, HLA-DQA1, RSPO4, MUC19, TCF7L1, COL26A1, HOXA10, and C7orf61) that were identified (<xref ref-type="sec" rid="s12">Supplementary Table S1</xref>). DEcircRNAs and DEmRNAs were confirmed by a heatmap (<xref ref-type="fig" rid="F2">Figures 2A, D</xref>) and volcano plot, respectively (<xref ref-type="fig" rid="F2">Figures 2B, E</xref>). In addition, we marked DEGs on the genomic circle diagram to display the position of the DEGs on the chromosome in detail (<xref ref-type="fig" rid="F2">Figures 2C, F</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Identification of the significant expression changes of circRNAs and mRNAs. <bold>(A)</bold> The heatmaps of DEcircRNAs. <bold>(B)</bold> The volcano plots of DEcircRNAs. <bold>(C)</bold> The genomic circle diagram of DEcircRNAs. <bold>(D)</bold> The heatmaps of DEmRNAs. <bold>(E)</bold> The volcano plots of DEmRNAs. <bold>(F)</bold> The genomic circle diagram of DEmRNAs. The red, blue/green and black dots represent genes that are upregulated, downregulated and not significantly differentially expressed in the heatmaps or volcano plots. Con, Control Group; COPD, Chronic obstructive pulmonary disease.</p>
</caption>
<graphic xlink:href="fgene-15-1376721-g002.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Functional and pathway enrichment analyses</title>
<p>GO functional enrichment analysis showed that the main pathways enriched for biological process primarily were the response to resveratrol, response to metformin, positive regulation of interleukin (IL)-18 production, positive regulation of IL-5 secretion, multicellular organismal signalling, positive regulation of NLRP3 inflammasome complex assembly, positive regulation of endothelial cell chemotaxis, response to nitrite, cellular response to nitrite, cell-substrate adhesion, and axonal fasciculation. The cellular component included the cytoplasmic side of the plasma membrane, cell surface, axonal surface, symmetric synapse, side of the membrane, and myosin complex, major histocompatibility complex (MHC) class II protein complex, and MHC protein complex. The MFs included IL-2 binding, talin binding, protein-coupled neurotensin receptor activity, triplex DNA binding, transketolase, transferase activity, and transferring aldehyde or ketones groups <xref ref-type="fig" rid="F3">Figure 3A</xref> shows the top 10 clusters of GO functional enrichment analysis of DEmRNAs.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Functional and pathway enrichment analysis. <bold>(A)</bold> Top 10 clusters GO Functional enrichment analysis of DEmRNAs. <bold>(B)</bold> Top 20 clusters KEGG pathway enrichment analysis of DEmRNAs.</p>
</caption>
<graphic xlink:href="fgene-15-1376721-g003.tif"/>
</fig>
<p>KEGG pathway enrichment analysis found that the signalling pathways related to COPD included the differentiation of Th1, Th2 and Th17 cells, apelin signalling pathway, AMPK signalling pathway, Wnt signalling pathway, JAK-STAT signalling pathway, and PI3K-Akt signalling pathway. <xref ref-type="fig" rid="F3">Figure 3B</xref> shows the top 20 clusters of KEGG pathway enrichment analysis of DEmRNAs.</p>
</sec>
<sec id="s3-5">
<title>3.5 PPI network</title>
<p>As shown in <xref ref-type="fig" rid="F4">Figure 4A</xref>, the DEmRNAs are plotted as a PPI network showing the interaction between multiple proteins. In the PPI map, the core genes in the network are MYO16, MYL4, SCN4A, NRCAM, HMCN1, MYOM2, and IQSEC3.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>PPI network and circRNA-mediated ceRNA Regulatory Network. <bold>(A)</bold> PPI network analysis of DE mRNAs. <bold>(B)</bold> The construction of the circRNA-miRNA-mRNA ceRNA regulatory network. Red nodes indicate upregulated RNAs, green nodes indicate downregulated RNAs, and blue nodes indicate none detected miRNAs. Circles indicate DEmiRNAs, rectangles indicate DEcircRNAs, and diamonds indicate DEmRNAs.</p>
</caption>
<graphic xlink:href="fgene-15-1376721-g004.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 Prediction of small-molecule drugs</title>
<p>Based on DEGs between the COPD patients and healthy controls, the CMap database was utilized to screen candidate small-molecule drugs. Suitable parameters included a significant <italic>p</italic>-value &#x3c; 0.05 and an absolute enrichment value &#x3e; 0.80. As <xref ref-type="table" rid="T3">Table 3</xref> shows, there were negative correlations between hycanthone, ascorbic acid, canavanine, puromycin and lincomycin; therefore, they were considered to be potential drugs for the treatment of COPD.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Results of the connectivity map analysis.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Rank</th>
<th align="center">CMap name</th>
<th align="center">Mean</th>
<th align="center">N</th>
<th align="center">Enrichment</th>
<th align="center">
<italic>p</italic>-value</th>
<th align="center">Specificity</th>
<th align="center">Percent</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">sulfinpyrazone</td>
<td align="right">0.325</td>
<td align="right">4</td>
<td align="right">0.816</td>
<td align="right">0.00211</td>
<td align="center">0</td>
<td align="center">50</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">hycanthone</td>
<td align="right">&#x2212;0.649</td>
<td align="right">4</td>
<td align="right">&#x2212;0.882</td>
<td align="right">0.00048</td>
<td align="center">0</td>
<td align="center">100</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">ascorbic acid</td>
<td align="right">&#x2212;0.587</td>
<td align="right">4</td>
<td align="right">&#x2212;0.868</td>
<td align="right">0.0006</td>
<td align="center">0</td>
<td align="center">100</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">canavanine</td>
<td align="right">&#x2212;0.602</td>
<td align="right">3</td>
<td align="right">&#x2212;0.855</td>
<td align="right">0.00603</td>
<td align="center">0.0103</td>
<td align="center">100</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">puromycin</td>
<td align="right">&#x2212;0.433</td>
<td align="right">4</td>
<td align="right">&#x2212;0.814</td>
<td align="right">0.00223</td>
<td align="center">0.0448</td>
<td align="center">75</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">lincomycin</td>
<td align="right">&#x2212;0.517</td>
<td align="right">3</td>
<td align="right">&#x2212;0.806</td>
<td align="right">0.01448</td>
<td align="center">0.0108</td>
<td align="center">66</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-7">
<title>3.7 Construction of the circRNA-mediated ceRNA regulatory network</title>
<p>The ceRNA regulatory network of circRNAs-miRNAs-mRNAs (<xref ref-type="fig" rid="F4">Figure 4B</xref>) contains 60 DEcircRNAs (23 upregulated, 37 downregulated), 39 predicted DE miRNAs (DEmiRNAs; 28 upregulated, 11 downregulated) and 13 DEmRNAs (5 upregulated, 8 downregulated). There were 225 ceRNA pairs in the network. As shown in <xref ref-type="sec" rid="s12">Supplementary Table S2</xref>, the negative regulatory relationships among the DEcircRNAs, DEmiRNAs, and DEmRNAs in the ceRNA network are listed in detail.</p>
</sec>
<sec id="s3-8">
<title>3.8 Validation of differentially expressed genes</title>
<p>To verify the RNA sequencing data, we selected six identified circRNAs for the analysis of RT-qPCR including three upregulated circRNAs and three downregulated circRNAs, and six candidate mRNAs including three upregulated mRNAs and three downregulated mRNAs. The results showed that hsa_circ_006155, hsa_circ_031080, hsa_circ_041434, MYZAP, NRCAM and SHE were increased, whereas hsa_circ_007446, hsa_circ_019015, hsa_circ_038146, HYDIN, MUC19, and RNF17 were decreased in COPD patients versus normal control samples. The results were consistent with the RNA-Seq data (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>The expression of RNAs in the COPD group compared with the normal control group. <bold>(A)</bold> Expression of three upregulated and three downregulated circRNAs. <bold>(B)</bold> Expression of three upregulated and three downregulated mRNAs.</p>
</caption>
<graphic xlink:href="fgene-15-1376721-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>COPD is a slowly irreversible and progressive disease of the lungs, and it is a major cause of morbidity and mortality worldwide. Long-term cigarette smoke exposure is the most important risk factor in the development of COPD. Therefore, in our study, we identified the expression patterns of circRNAs and mRNAs in PBMCs of long-term male smokers based on high-throughput RNA-Seq technology. By comparing circRNAs and mRNAs in the COPD and healthy control groups, a set of DEcircRNAs and DEmRNAs were identified in the COPD group. Subsequently, through a series of bioinformatics methods, a ceRNA network was constructed, and potential biomarkers and molecular targets were screened. To the best of our knowledge, transcriptome analysis of circRNAs and mRNAs in male smokers with COPD was performed in this study for the first time. This analysis was valuable to provide a reliable theoretical basis for COPD researchers.</p>
<p>With the rapid development of NGS and bioinformatics methods, circRNAs have been shown to be widespread in different species, where they are highly conserved, tissue-specific, and timing-specific molecules that have many important biological functions (<xref ref-type="bibr" rid="B21">Memczak et al., 2013</xref>). In a recent review, Lei and his team provided a comprehensive summary of the expression and/or function of various circRNAs related to multiple types of tumours, including the digestion, respiration, and urinary system tumours, and concluded that circRNAs may be used as helpful biomarkers or therapeutic targets in human tumours and have potential clinical application value (<xref ref-type="bibr" rid="B18">Lei et al., 2019</xref>). However, research on the functions and mechanisms of circRNAs in COPD is still in its infancy. The latest research identified the expression of circRNAs in PBMCs from patients with COPD by bioinformatic analysis, and validated the microarray data by RT-qPCR (<xref ref-type="bibr" rid="B6">Duan et al., 2020</xref>). Further, by sequencing the exosomal RNA and single-cell transcriptome of PBMC in COPD, Pei et al.&#x27;s study characterized numerous potential molecular aspects of the disease and suggested a probable link between compromised immune function and the advancement of COPD (<xref ref-type="bibr" rid="B23">Pei et al., 2022</xref>). Another study showed that cigarette smoke extract alters the genome-wide profiles of circRNAs in primary human small airway epithelial cells, suggesting that circRNAs might be involved in the development of COPD (<xref ref-type="bibr" rid="B43">Zeng et al., 2019</xref>). In contrast, our research was based on PBMCs from long-term smoking participants, and 114 significantly DEcircRNAs were screened, of which 57 DEcircRNAs were overexpressed, and 57 DEcircRNAs were underexpressed in the COPD group in comparison to the those in the control group, further indicating that DEcircRNAs may be used as biomarkers in male smokers with COPD.</p>
<p>GO functional enrichment analysis revealed that important functions related to COPD were the response to resveratrol and metformin and the regulation of IL-18, IL-5 and NLRP3 inflammasomes. As summarized from previous studies, the beneficial effects of resveratrol on anti-inflammatory and antioxidant activities have been confirmed in relation to many diseases, including ageing, obesity, diabetes and COPD (<xref ref-type="bibr" rid="B19">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B1">Beijers et al., 2018</xref>). Metformin is often used in the clinical treatment of diabetes. Interestingly, studies have shown that the use of metformin in diabetic patients can reduce not only the risk of COPD but also the adverse prognostic outcome of COPD (<xref ref-type="bibr" rid="B16">Ho et al., 2019</xref>; <xref ref-type="bibr" rid="B36">Tseng, 2019</xref>). It is well known that the occurrence and severity of COPD is related to abnormal airway inflammation. Activated inflammatory cells can produce a variety of the proinflammatory cytokines ILs, including IL-1 and IL-6 (<xref ref-type="bibr" rid="B5">Dima et al., 2015</xref>), and the multiprotein complex NLRP3 inflammasome can produce IL-1&#x3b2; and IL-18, which may contribute to the development of airway inflammation in patients with COPD (<xref ref-type="bibr" rid="B38">Wang et al., 2018b</xref>).</p>
<p>KEGG pathway enrichment analysis revealed that the signalling pathways related to COPD included the differentiation of Th1, Th2 and Th17 cells, AMPK signalling pathway, Wnt signalling pathway, JAK-STAT signalling pathway, and PI3K-Akt signalling pathway. These pathways have been reported in previous studies by mediating different molecular signalling pathways, regulating the expression of related genes, and then participating in the occurrence and development of COPD. In particular, these pathways mediate the inflammatory process of COPD by regulating the release and expression of inflammation-related cytokines and mediators (<xref ref-type="bibr" rid="B15">Heijink et al., 2013</xref>; <xref ref-type="bibr" rid="B4">Cui et al., 2018</xref>; <xref ref-type="bibr" rid="B40">Wei and Sheng Li, 2018</xref>; <xref ref-type="bibr" rid="B44">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="B42">Yu et al., 2020</xref>; <xref ref-type="bibr" rid="B45">Zhao et al., 2020</xref>). A study found that autophagy was significantly enhanced in locomotor muscles of stable patients with COPD by activation of the AMPK signalling pathway (<xref ref-type="bibr" rid="B13">Guo et al., 2013</xref>). Additionally, in our study, the core genes were MYO16, MYL4, SCN4A, NRCAM, HMCN1, MYOM2, and IQSEC3 in the PPI network, but none of these genes have been reported in COPD. Hycanthone, ascorbic acid, canavanine, puromycin and lincomycin are considered to be potential drugs for the treatment of COPD in the current study. Ascorbic acid is also known as vitamin C, which can not only improve the nutritional and antioxidant status of COPD (<xref ref-type="bibr" rid="B24">Pirabbasi et al., 2016</xref>) but also play a preventive role (<xref ref-type="bibr" rid="B22">Park et al., 2016</xref>). More research is needed to determine the functions of these genes and drugs.</p>
<p>In previous literature, the circRNA-related ceRNA mechanism in COPD has rarely been studied. Using cigarette smoke extraction or cigarette smoke to construct COPD cell models and mouse models, a previous study verified the ceRNA mechanism of circ0061052 <italic>in vivo</italic> and <italic>in vitro</italic> and concluded that circ0061052 was involved in cigarette smoke-induced epithelial-mesenchymal transition and airway remodelling in COPD by regulating miR-515-5p through a FoxC1/Snail regulatory axis (<xref ref-type="bibr" rid="B20">Ma et al., 2020</xref>). In our study, the circRNA-miRNA-mRNA ceRNA regulatory network contained 60 DEcircRNAs (23 upregulated, 37 downregulated), 39 predicted DEmiRNAs (28 upregulated, 11 downregulated) and 13 DEmRNAs (5 upregulated, 8 downregulated). There were 225 pairs of ceRNA regulatory relationships. Not surprisingly, multiple ceRNA regulatory relationship pairs related to the AMPK signalling pathway were screened, and the target gene was PPARGC1A, constituting 35 pairs of circRNA-miRNA-PPARGC1A (<xref ref-type="sec" rid="s12">Supplementary Table S2</xref>). The AMPK-PPARGC1A pathway is involved in an important biological process, autophagy, which has been previously confirmed (<xref ref-type="bibr" rid="B41">Yang et al., 2014</xref>). Whether the screened circRNA-related genes enriched in the AMPK pathway can mediate the AMPK-PPARGC1A pathway in COPD or whether other ceRNA pairs have corresponding functions in COPD, further studies are needed to determine its complex mechanism. This provides a viable foundation for more in-depth mechanistic research in the future.</p>
<p>There were some limitations in our study. First, the sample size is relatively small. The conclusions of this study require further verification in larger and more diverse cohorts. Second, the regulatory networks or mechanisms analysed in this study identified only the DEcircRNAs and DEmRNAs based on bioinformatics predictions and lacks <italic>in vitro</italic> and <italic>in vivo</italic> experiments to verify these results. More comprehensive analyses and further in-depth studies with <italic>in vitro</italic> and <italic>in vivo</italic> experiments and circRNA knockdown or overexpression experiments are still needed.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>In conclusion, this study identified a set of DEcircRNAs and DEmRNAs and revealed potentially important genes, pathways, new small-molecule drugs and a ceRNA regulatory network in male smokers with COPD. These circRNAs might become prospective diagnostic biomarkers and therapeutic targets in the clinic or provide potential AMPK-PPARGC1A-mediated autophagy ceRNA mechanism for COPD.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the GEO repository, accession number GSE268499.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The studies involving humans were approved by this study was approved by the Ethics Committee of The Affiliated Hospital of Yunnan University (No. 2020139). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>JZ: Data curation, Investigation, Software, Writing&#x2013;original draft. SX: Data curation, Investigation, Software, Writing&#x2013;original draft. JL: Data curation, Investigation, Software, Writing&#x2013;original draft. TL: Writing&#x2013;original draft. ZF: Data curation, Software, Writing&#x2013;review and editing. YZ: Investigation, Writing&#x2013;review and editing. JB: Investigation, Writing&#x2013;review and editing. LZ: Investigation, Writing&#x2013;review and editing. XL: Investigation, Writing&#x2013;review and editing. JY: Conceptualization, Project administration, Writing&#x2013;review and editing. XX: Conceptualization, Funding acquisition, Writing&#x2013;review and editing, Project administration.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by a grant from the National Natural Science Foundation of China (No. 82160016), Famous Doctors of High-level Talent Training Support Program of Yunnan Province (No. YNWR-MY-2020-013), the Special and Joint Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University (No. 202201AY070001-265 and 202301AY070001-189), and Yunnan Provincial Innovation Team for Respiratory and Pulmonary Circulation Diseases (No. 202405AS350018).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2024.1376721/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2024.1376721/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material>
<label>SUPPLEMENTARY TABLE S1</label>
<caption>
<p>Differentially expressed circRNAs and mRNAs.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>SUPPLEMENTARY TABLE S2</label>
<caption>
<p>Relationship between negative regulation of circRNA, miRNA, and mRNA in the ceRNA network.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table2.XLSX" id="SM1" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.XLSX" id="SM2" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table1.DOCX" id="SM3" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table9.XLSX" id="SM4" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table6.XLSX" id="SM5" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM6" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table11.XLSX" id="SM7" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table4.XLSX" id="SM8" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table10.XLSX" id="SM9" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table12.XLSX" id="SM10" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table5.XLSX" id="SM11" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table7.XLSX" id="SM12" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table8.XLSX" id="SM13" mimetype="application/XLSX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beijers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gosker</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Schols</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope?</article-title> <source>Curr. Opin. Clin. Nutr. Metab. Care</source> <volume>21</volume> (<issue>2</issue>), <fpage>138</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1097/MCO.0000000000000444</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chin</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>cytoHubba: identifying hub objects and sub-networks from complex interactome</article-title>. <source>BMC Syst. Biol.</source> <volume>8</volume> (<issue>Suppl. 4</issue>), <fpage>S11</fpage>. <pub-id pub-id-type="doi">10.1186/1752-0509-8-s4-s11</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cocquerelle</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mascrez</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>H&#xa8;&#xa6;tuin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bailleul</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Mis-splicing yields circular RNA molecules</article-title>. <source>Faseb J.</source> <volume>7</volume> (<issue>1</issue>), <fpage>155</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1096/fasebj.7.1.7678559</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Nrf2 attenuates inflammatory response in COPD/emphysema: crosstalk with Wnt3a/&#x3b2;-catenin and AMPK pathways</article-title>. <source>J. Cell. Mol. Med.</source> <volume>22</volume> (<issue>7</issue>), <fpage>3514</fpage>&#x2013;<lpage>3525</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.13628</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dima</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Koltsida</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Katsaounou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vakali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koutsoukou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koulouris</surname>
<given-names>N. G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD)</article-title>. <source>Cytokine</source> <volume>74</volume> (<issue>2</issue>), <fpage>313</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2015.04.008</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Identification and bioinformatic analysis of circular RNA expression in peripheral blood mononuclear cells from patients with chronic obstructive pulmonary disease</article-title>. <source>Int. J. Chron. Obstruct Pulmon Dis.</source> <volume>15</volume>, <fpage>1391</fpage>&#x2013;<lpage>1401</lpage>. <pub-id pub-id-type="doi">10.2147/COPD.S252896</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Habib</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Xeno-miRNet: a comprehensive database and analytics platform to explore xeno-miRNAs and their potential targets</article-title>. <source>PeerJ</source> <volume>6</volume>, <fpage>e5650</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.5650</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Siklenka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kimmins</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>miRNet&#x2013;dissecting miRNA-target interactions and functional associations through network-based visual analysis</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume> (<issue>W1</issue>), <fpage>W135</fpage>&#x2013;<lpage>W141</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw288</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cellular stress-modulating drugs can potentially Be identified by <italic>in silico</italic> screening with connectivi ty map (CMap)</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>22</issue>), <fpage>5601</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20225601</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Ryde</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van der Burg</surname>
<given-names>N. M. D.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Larsson-Callerfelt</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Westergren-Thorsson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bjermer</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Lung fibroblasts from chronic obstructive pulmonary disease subjects have a deficient gene expression response to cigarette smoke extract compared to healthy</article-title>. <source>Int. J. Chron. Obstruct Pulmon Dis.</source> <volume>18</volume>, <fpage>2999</fpage>&#x2013;<lpage>3014</lpage>. <pub-id pub-id-type="doi">10.2147/copd.S422508</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gbd</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systemati c analysis for the Global Burden of Disease Study 2017</article-title>. <source>Lancet</source> <volume>392</volume> (<issue>10159</issue>), <fpage>1684</fpage>&#x2013;<lpage>1735</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31891-9</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<collab>Global burden</collab> (<year>2024</year>). <article-title>Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021</article-title>. <source>Lancet.</source> <volume>403</volume>, <fpage>2100</fpage>&#x2013;<lpage>2132</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(24)00367-2</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gosker</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Schols</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kapchinsky</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bourbeau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sandri</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>188</volume> (<issue>11</issue>), <fpage>1313</fpage>&#x2013;<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201304-0732OC</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagstad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bjerg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ekerljung</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Backman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lindberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>R?nmark</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Passive smoking exposure is associated with increased risk of COPD in never smokers</article-title>. <source>Chest</source> <volume>145</volume> (<issue>6</issue>), <fpage>1298</fpage>&#x2013;<lpage>1304</lpage>. <pub-id pub-id-type="doi">10.1378/chest.13-1349</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heijink</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>de Bruin</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>van den Berge</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bennink</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Brandenburg</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Gosens</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstr uctive pulmonary disease</article-title>. <source>Thorax</source> <volume>68</volume> (<issue>8</issue>), <fpage>709</fpage>&#x2013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1136/thoraxjnl-2012-201667</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pul monary disease</article-title>. <source>Respir. Res.</source> <volume>20</volume> (<issue>1</issue>), <fpage>69</fpage>. <pub-id pub-id-type="doi">10.1186/s12931-019-1035-9</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression</article-title>. <source>J. Cell. Mol. Med.</source> <volume>23</volume> (<issue>9</issue>), <fpage>6112</fpage>&#x2013;<lpage>6119</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.14477</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Circular RNA: a novel biomarker and therapeutic target for human cancers</article-title>. <source>Int. J. Med. Sci.</source> <volume>16</volume> (<issue>2</issue>), <fpage>292</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.7150/ijms.28047</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X. J.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Effects of resveratrol and genistein on nuclear factor-&#x3ba;B, tumor necrosis factor-&#x3b1; and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease</article-title>. <source>Mol. Med. Rep.</source> <volume>13</volume> (<issue>5</issue>), <fpage>4266</fpage>&#x2013;<lpage>4272</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2016.5057</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Circ0061052 regulation of FoxC1/Snail pathway via miR-515-5p is involved in the epithelial-mesenchyma l transition of epithelial cells during cigarette smoke-induced airway remodeling</article-title>. <source>Sci. Total Environ.</source> <volume>746</volume>, <fpage>141181</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.141181</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Memczak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Elefsinioti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Torti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rybak</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Circular RNAs are a large class of animal RNAs with regulatory potency</article-title>. <source>Nature</source> <volume>495</volume> (<issue>7441</issue>), <fpage>333</fpage>&#x2013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1038/nature11928</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>K. H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Dietary vitamin C intake protects against COPD: the korea national health and nutrition examination S urvey in 2012</article-title>. <source>Int. J. Chron. Obstruct Pulmon Dis.</source> <volume>11</volume>, <fpage>2721</fpage>&#x2013;<lpage>2728</lpage>. <pub-id pub-id-type="doi">10.2147/COPD.S119448</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD</article-title>. <source>Respir. Res.</source> <volume>23</volume> (<issue>1</issue>), <fpage>260</fpage>. <pub-id pub-id-type="doi">10.1186/s12931-022-02182-8</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirabbasi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shahar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Manaf</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Rajab</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Manap</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Efficacy of ascorbic acid (vitamin C) and/N-acetylcysteine (NAC) supplementation on nutritional and A ntioxidant status of male chronic obstructive pulmonary disease (COPD) patients</article-title>. <source>J. Nutr. Sci. Vitaminol. (Tokyo)</source> <volume>62</volume> (<issue>1</issue>), <fpage>54</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.3177/jnsv.62.54</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Circular RNAs in hepatocellular carcinoma: biomarkers, functions and mechanisms</article-title>. <source>Life Sci.</source> <volume>231</volume>, <fpage>116660</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2019.116660</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richmond</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Blackburn</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Tufenkjian</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Loss of p73 expression contributes to chronic obstructive pulmonary disease</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>209</volume> (<issue>2</issue>), <fpage>153</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.202303-0503OC</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salmena</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Poliseno</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kats</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>P. P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?</article-title> <source>Cell.</source> <volume>146</volume> (<issue>3</issue>), <fpage>353</fpage>&#x2013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.07.014</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/F OXO3a Axis in breast cancer</article-title>. <source>Mol. Ther.</source> <volume>27</volume> (<issue>9</issue>), <fpage>1638</fpage>&#x2013;<lpage>1652</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2019.05.011</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>B?r</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thum</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Circular RNAs: a novel class of functional RNA molecules with a therapeutic perspective</article-title>. <source>Mol. Ther.</source> <volume>27</volume> (<issue>8</issue>), <fpage>1350</fpage>&#x2013;<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2019.07.001</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markiel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozier</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res.</source> <volume>13</volume> (<issue>11</issue>), <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>X. R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>R. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Circular RNA expression of peripheral blood mononuclear cells associated with risk of acute exacerbation in smoking chronic obstructive pulmonary disease</article-title>. <source>Int. J. Chron. Obstruct Pulmon Dis.</source> <volume>19</volume>, <fpage>789</fpage>&#x2013;<lpage>797</lpage>. <pub-id pub-id-type="doi">10.2147/copd.S448759</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>J. Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P. Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Circular RNAs in digestive system cancer: potential biomarkers and therapeutic targets</article-title>. <source>Am. J. Cancer Res.</source> <volume>8</volume> (<issue>7</issue>), <fpage>1142</fpage>&#x2013;<lpage>1156</lpage>.</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer</article-title>. <source>Cancer Lett.</source> <volume>473</volume>, <fpage>139</fpage>&#x2013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2019.12.043</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kadota</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>TCC: an R package for comparing tag count data with robust normalization strategies</article-title>. <source>BMC Bioinforma.</source> <volume>14</volume>, <fpage>219</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-14-219</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Junge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wyder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume> (<issue>D1</issue>), <fpage>D607-D613</fpage>&#x2013;<lpage>d613</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tseng</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metformin and risk of chronic obstructive pulmonary disease in diabetes patients</article-title>. <source>Diabetes Metab.</source> <volume>45</volume> (<issue>2</issue>), <fpage>184</fpage>&#x2013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.diabet.2018.05.001</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018a</year>). <article-title>Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary He alth [CPH] study): a national cross-sectional study</article-title>. <source>Lancet</source> <volume>391</volume> (<issue>10131</issue>), <fpage>1706</fpage>&#x2013;<lpage>1717</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)30841-9</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2018b</year>). <article-title>NLRP3 inflammasome involves in the acute exacerbation of patients with chronic obstructive pulmonary disease</article-title>. <source>Inflammation</source> <volume>41</volume> (<issue>4</issue>), <fpage>1321</fpage>&#x2013;<lpage>1333</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-018-0780-0</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y. G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-13 07</article-title>. <source>Cancer Lett.</source> <volume>460</volume>, <fpage>128</fpage>&#x2013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2019.06.007</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sheng Li</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary diseas e</article-title>. <source>J. Int. Med. Res.</source> <volume>46</volume> (<issue>9</issue>), <fpage>3890</fpage>&#x2013;<lpage>3902</lpage>. <pub-id pub-id-type="doi">10.1177/0300060518781642</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. H.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The AMPK-PPARGC1A pathway is required for antimicrobial host defense through activation of autophagy</article-title>. <source>Autophagy</source> <volume>10</volume> (<issue>5</issue>), <fpage>785</fpage>&#x2013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.4161/auto.28072</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Th1/Th17 cytokine profiles are associated with disease severity and exacerbation frequency in COPD Pa tients</article-title>. <source>Int. J. Chron. Obstruct Pulmon Dis.</source> <volume>15</volume>, <fpage>1287</fpage>&#x2013;<lpage>1299</lpage>. <pub-id pub-id-type="doi">10.2147/COPD.S252097</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Cigarette smoke extract alters genome-wide profiles of circular RNAs and mRNAs in primary human small airway epithelial cells</article-title>. <source>J. Cell. Mol. Med.</source> <volume>23</volume> (<issue>8</issue>), <fpage>5532</fpage>&#x2013;<lpage>5541</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.14436</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H. X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>HIF-1&#x3b1; promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3 K/AKT pathway</article-title>. <source>Eur. Rev. Med. Pharmacol. Sci.</source> <volume>22</volume> (<issue>18</issue>), <fpage>6077</fpage>&#x2013;<lpage>6084</lpage>. <pub-id pub-id-type="doi">10.26355/eurrev_201809_15946</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT/NF-&#x3ba;B pathway</article-title>. <source>Aging (Albany NY)</source> <volume>12</volume> (<issue>10</issue>), <fpage>9125</fpage>&#x2013;<lpage>9138</lpage>. <pub-id pub-id-type="doi">10.18632/aging.103180</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>